Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Melissa officinalis (Lemon Balm) in alloxan-induced diabetic rats

被引:0
作者
Khodsooz, Sedigheh [1 ]
Moshtaghian, Jamal [1 ]
Eivani, Mehdi [2 ,3 ]
机构
[1] Univ Isfahan, Div Anim physiol, Dept Biol, Fac Sci, Esfahan, Iran
[2] Univ Tehran, Sch Biol, Dept Anim Biol, Coll Sci, Tehran, Iran
[3] Univ Tehran, Ctr Excellence Phylogeny Living Organisms, Coll Sci, Tehran, Iran
来源
PHYSIOLOGY AND PHARMACOLOGY | 2016年 / 20卷 / 01期
关键词
Diabetes; Hydroalcoholic Extract; Melissa Officinalis; Alloxan; Rat;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Diabetes mellitus is a metabolic disorder of the endocrine system leading to increased blood glucose concentration in the patients. As a basic treatment for managing the blood glucose level, insulin or hypoglycemic medications are used but herbal medicines are more favored. The design of this research project was to study the therapeutic effect of hydroalcoholic extract of Melissa officinalis (HEMO) in diabetic rats. Methods: Twenty-five Wistar male rats weighing 220+/-25 grams were distributed semi-randomly into five groups of five each. Group 1 and 2 was respectively the control and diabetic animals. Group 3, 4 and 5 were the diabetic animals treated with HEMO either at 20, 100 or 500 mg/Kg of body weight. To induce diabetic rat models, each animals received a single intraperitoneal injection of alloxan at the dose of 120 mg/Kg. All treatments with HEMO performed daily via gavage for a period of 4 weeks. Then, blood samples were collected from all animals to measure the blood glucose level, cholesterol, triglycerides, LDL and HDL. Results: The results of this study indicated significant (P<0.05) decreases in blood sugar level, cholesterol, triglycerides and LDL in diabetic rats treated with HEMO. In addition, significant (P<0.05) increase in HDL level was observed in HEMO treated diabetic rats compared with the non-treated ones. Conclusion: HEMO has significant effects on attenuating the blood sugar level, serum lipids and lipoproteins levels, whereas it improves the HDL level. These effect might be attributed to the antioxidant benefits of flavonoids which are present in HEMO.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 34 条
[1]   INVESTIGATIONS OF THE CONTENT AND COMPOSITION OF ESSENTIAL OIL OF MELISSA-OFFICINALIS .2. CONTENT AND COMPOSITION OF M-OFFICINALIS OIL IN RELATION TO LEAF POSITION AND HARVEST TIME [J].
ADZET, T ;
PONZ, R ;
WOLF, E ;
SCHULTE, E .
PLANTA MEDICA, 1992, 58 (06) :562-564
[2]  
Aharizad S., 2012, Annals of Biological Research, V3, P5748
[3]   Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomised, placebo controlled trial [J].
Akhondzadeh, S ;
Noroozian, M ;
Mohammadi, M ;
Ohadinia, S ;
Jamshidi, AH ;
Khani, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (07) :863-866
[5]   Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats [J].
Aragao, Danielle M. O. ;
Guarize, Lyvia ;
Lanini, Juliana ;
da Costa, Juliana C. ;
Garcia, Raul M. G. ;
Scio, Elita .
JOURNAL OF ETHNOPHARMACOLOGY, 2010, 128 (03) :629-633
[6]   Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats [J].
Asgary, Sedigheh ;
Parkhideh, Sahar ;
Solhpour, Amirreza ;
Madani, Hossein ;
Mahzouni, Parvin ;
Rahimi, Parivash .
JOURNAL OF MEDICINAL FOOD, 2008, 11 (03) :533-538
[7]  
Asgary S, 2012, J RES MED SCI, V17, P386
[8]   Neuroprotective properties of Melissa officinalis after hypoxic-ischemic injury both in vitro and in vivo [J].
Bayat, Mohammad ;
Tameh, Abolfazl Azami ;
Ghahremani, Mohammad Hossein ;
Akbari, Mohammad ;
Mehr, Shahram Ejtemaei ;
Khanavi, Mahnaz ;
Hassanzadeh, Gholamreza .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 20
[9]   Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats:: A morphological and biochemical study [J].
Bolkent, S ;
Yanardag, R ;
Karabulut-Bulan, O ;
Yesilyaprak, B .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 99 (03) :391-398
[10]  
Bounihi A, 2013, ADV PHARM SCI, V2013